Mode
Text Size
Log in / Sign up

Oncology

592 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Report describes COVID-19 deaths among US cancer survivors in 2021
Oncology
Report describes COVID-19 deaths among US cancer survivors in 2021 How many cancer survivors died with COVID-19 listed as a cause in 2021?
A descriptive report examined deaths among cancer survivors in the United States during 2021 where COVID-19 was listed as an underlying caus…
A 2021 report confirms COVID-19 was a documented cause of death for some cancer survivors, though it lacks specific numbers or comparisons t…
Phase 1 trial of WVT078 with/without WHG626 shows preliminary activity in relapsed/refractory multiple myeloma
Oncology Phase I
Phase 1 trial of WVT078 with/without WHG626 shows preliminary activity in relapsed/refractory multiple myeloma Can a new combination therapy help when multiple myeloma returns?
A phase 1 dose-escalation trial in 56 patients with relapsed/refractory multiple myeloma assessed the BCMA×CD3 bispecific antibody WVT078 al…
Adding a second drug to a new antibody therapy nearly doubled response rates in early trials for patients with returning multiple myeloma.
Phase II trial opens for Viscum album extract adjuvant therapy in relapsed osteosarcoma
Oncology Phase II
Phase II trial opens for Viscum album extract adjuvant therapy in relapsed osteosarcoma Early study explores mistletoe extract as additional treatment for relapsed bone cancer in young people
A Phase II trial is now open to evaluate adjuvant Viscum album extract (Iscador® P) in children and AYAs with relapsed, resectable osteosarc…
A pilot study found that adding mistletoe extract after surgery helped 55% of young people with relapsed bone cancer stay alive without dise…
CDSS Dashboard Implementation Associated with Higher CRPC Detection in Prostate Cancer Cohort
Oncology Cohort
CDSS Dashboard Implementation Associated with Higher CRPC Detection in Prostate Cancer Cohort Can a digital dashboard help doctors spot prostate cancer progression sooner?
A retrospective single-centre cohort study of prostate cancer patients on ADT found that implementing a Clinical Decision Support System das…
A digital dashboard helped doctors spot prostate cancer progression sooner and catch unstable warning signs in patients already on hormone t…
Machine learning algorithm predicts skip metastasis in papillary thyroid cancer in retrospective cohort
Oncology Cohort
Machine learning algorithm predicts skip metastasis in papillary thyroid cancer in retrospective cohort Can a computer help spot tricky thyroid cancer spread?
A retrospective, single-center cohort study of 361 patients undergoing thyroidectomy with lymph node dissections developed a machine learnin…
A computer program can spot tricky thyroid cancer spread that jumps over nearby nodes, helping surgeons plan more effective operations befor…
Radiomics-ML model predicts invasiveness in subcentimeter subsolid lung adenocarcinoma
Oncology Cohort
Radiomics-ML model predicts invasiveness in subcentimeter subsolid lung adenocarcinoma AI model shows promise for predicting cancer invasiveness in small lung nodules
A two-center retrospective cohort study of 260 patients with surgically confirmed subcentimeter subsolid lung adenocarcinoma developed and v…
An AI model predicts whether tiny, hazy lung spots are invasive cancer with 79% accuracy, offering a new tool for doctors to spot dangerous …
Global disparities persist in access to molecular diagnostics and novel therapies for advanced NSCLC
Oncology Sys. Review
Global disparities persist in access to molecular diagnostics and novel therapies for advanced NSCLC Why does where you live still determine your lung cancer care?
A narrative review synthesizing evidence from guidelines and real-world studies describes persistent global disparities in access to molecul…
Where you live still decides if you get advanced lung cancer tests and treatments, creating a harsh reality where geography and income deter…
Umbrella review finds 32% breast self-examination prevalence in low- and middle-income countries
Oncology Meta-analysis
Umbrella review finds 32% breast self-examination prevalence in low- and middle-income countries Study finds about one-third of women in lower-income countries practice breast self-exams
An umbrella review of systematic reviews and meta-analyses involving 110,622 participants across low- and middle-income countries found a po…
About one in three women in lower-income countries regularly checks their own breasts for changes, yet practice rates vary widely across com…
Case report describes intracranial WHO Grade II ependymoma with rare lipomatous metaplasia
Oncology Sys. Review
Case report describes intracranial WHO Grade II ependymoma with rare lipomatous metaplasia Doctors report rare case of brain tumor containing fat tissue in young man
A case report and literature review describes a 28-year-old male with an incidentally discovered intracranial mass. Histopathology following…
A rare brain tumor containing fat tissue was found in a young man, prompting doctors to review similar cases to help identify this unique va…
Meta-analysis finds MyoD1 immunopositivity common in retroperitoneal spindle cell/sclerosing rhabdomyosarcoma
Oncology Meta-analysis
Meta-analysis finds MyoD1 immunopositivity common in retroperitoneal spindle cell/sclerosing rhabdomyosarcoma What makes a rare, aggressive abdominal cancer so hard to treat?
A meta-analysis and institutional case series examined adult patients with retroperitoneal spindle cell/sclerosing rhabdomyosarcoma (Sc/SRMS…
A rare abdominal cancer often grows huge and invades nearby organs like kidneys, with a third of cases carrying a specific gene mutation.
Prostate cancer death rates decreased among US males from 1999 to 2017
Oncology
Prostate cancer death rates decreased among US males from 1999 to 2017 Prostate cancer deaths dropped by nearly half in the US over two decades.
An observational analysis of US vital statistics from 1999 to 2017 found the age-adjusted prostate cancer death rate among males decreased f…
Prostate cancer deaths in the US dropped nearly half between 1999 and 2017, with the death rate falling from 31.3 to 18.7 per 100,000 men.
Lung cancer incidence decreased more in metropolitan than nonmetropolitan US counties from 2007-2016
Oncology
Lung cancer incidence decreased more in metropolitan than nonmetropolitan US counties from 2007-2016 Did lung cancer rates fall faster in cities than rural areas?
An observational study of US counties from 2007-2016 found lung cancer incidence rates decreased more in metropolitan than nonmetropolitan c…
Lung cancer rates dropped faster in U.S. cities than rural areas between 2007 and 2016, showing progress isn't happening at the same pace ev…